You are here:

Home
NICE Guidance
Conditions and diseases
Cystic fibrosis

OxyMask for delivering oxygen therapy

Medtech innovation briefing
Reference number: MIB160
Published: 27 September 2018

Download (PDF)

Overview
Summary
The technology
Regulatory information
Equality considerations
Clinical and technical evidence
Specialist commentator comments
Specialist commentators
Development of this briefing

Regulatory information

OxyMask is a CE marked class IIa medical device.

Next page Equality considerations Previous page The technology